<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE301nnn/GSE301733/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type> Other</gds_type><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301733</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>CITEseq of hepatic CD4+ T cells from healthy mice and mice with steatohepatitis</name><description>Unresolved inflammation and fibrosis are the two key features of metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of steatotic liver disease that can evolve into cirrhosis and liver cancer. To better understand the role of CD4⁺ T cells in the pathogenesis of MASH, we comprehensively characterized hepatic CD4⁺ T cells in murine MASH at a single-cell protein and transcriptional level. CITE-sequencing revealed a marked shift in intrahepatic CD4⁺ T-cell composition in MASH, with enrichment of Th1, regulatory, and cytotoxic CD4⁺ T cells. Transcriptomic profiling also identified Tnfrsf4 (OX40) upregulation in hepatic CD4⁺ T cells during MASH. Together, these studies provide a proteogenomic single-cell atlas for hepatic CD4⁺ T cells and uncover a CD4⁺ T cell-dependent immunopathogenic circuit as a promising immunotherapeutic target to alleviate MASH and liver fibrosis.</description><dates><publication>2026/05/18</publication></dates><accession>GSE301733</accession><cross_references><GSM>GSM9088184</GSM><GSM>GSM9088185</GSM><GSM>GSM9088186</GSM><GSM>GSM9088187</GSM><GPL>30172</GPL><GSE>301733</GSE><taxon>Mus musculus</taxon><PMID>[42141897]</PMID></cross_references></HashMap>